Navigation Links
Goodwin Biotechnology is a Three-Category Winner in the 2012 CMO Leadership Awards
Date:10/25/2012

PLANTATION, Fla., Oct. 25, 2012 /PRNewswire/ -- Goodwin Biotechnology, Inc. (GBI) has been named a three-category winner in the 2012 CMO Leadership Awards presented by Life Science Leader magazine. GBI was rated in the top 20% for Innovation, Productivity and Regulatory.

"We at GBI are honored to be recognized in three categories of the CMO Leadership Awards, and consider it a testament to the quality of our people and their dedication to our customers," noted Bansi K. Bhan, Interim CEO at Goodwin Biotechnology, Inc.  "Regarding innovation, our scientists take great pride in identifying and implementing solutions to the most complex challenges. We are also proud of the Productivity award because we have established a history of meeting and exceeding our clients' expectations by consistently delivering on agreed upon objectives. Further, from a regulatory perspective, we focus on both quality and compliance as a single source for biologics development and manufacturing from cell line engineering and proof of concept through to cGMP manufacturing of late-stage clinical trial material."

Life Science Leader developed the annual CMO Leadership Awards in 2011 to honor top outsourcing industry performers based on leading research to better serve pharmaceutical and biopharmaceutical executives in the CMO vetting process. Life Science Leader partnered with the professional marketing research agency, Nice Insight, who created a methodology that combines the surveying of thousands of industry executives with other key analyses, such as review of marketing material, to facilitate better overall outsourcing collaborations.

Nice Insight is moving into its third year of conducting primary research on the outsourcing practices of pharmaceutical and biotechnology executives. For the 2012 CMO Leadership Awards survey, the sample size was over 10,000 executives who provided their p
'/>"/>

SOURCE Goodwin Biotechnology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Agricultural Biotechnology: Emerging Technologies and Global Markets
2. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
3. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
4. Antibiotics and Biotechnology Take Center Stage at Food Dialogues Event
5. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
6. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
7. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
8. Tina Fehr, Senior Product Manager For AmLactin, Upsher-Smith Laboratories Named PM360 Trailblazer Winner For Womens Health Brand Manager
9. Archbishop Desmond Tutu and the International Childrens Peace Prize Winners Launch Remember2015
10. Elsevier and Australasian Research Management Society Announce Winners of the 2012 Scopus Young Researcher of the Year Awards
11. Winner Medical Reports Third Quarter Fiscal 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MARSEILLE , Frankreich, July ... , Weltweite Exklusivlizenz der Universität ... Entwicklung von Tests auf SF3B1-Mutationen, einschließlich von ... Neuer Test weist Mutationen des SF3B1-Gens nach, ... einen günstigen Krankheitsverlauf vermuten lassen  ...
(Date:7/24/2014)... Inc. (NASDAQ: UPI ), a medical device ... products to treat voiding dysfunctions, today reported financial ... 30, 2014.  Global revenue for the ... to $4.1 million, as compared to $3.4 million ... Total revenue for the fiscal first quarter of ...
(Date:7/24/2014)... 2014  Mettler-Toledo International Inc. (NYSE: MTD ... below are the highlights: , Sales in ... with the prior year. Reported sales increased 5% which ... earnings per diluted share as reported (EPS) were $2.49, ... Adjusted EPS was $2.57, an increase of 9% over ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14
... by Novel, Motion Picture , , DENVER, June 22 ... a couple who conceives a child to save the life of ... release of the new movie starring Cameron Diaz on Friday. , ... B. Schoolcraft, the Nashes were able to select an embryo that ...
... , Findings point to new treatment options and research directions ... and treatment may offer a new therapeutic option for many ... bladder condition affecting as many as 8 million women and ... providers who treat them have long noticed a correlation between ...
Cached Medicine Technology:Inspiration for 'My Sister's Keeper' Speaks Out 2Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 2Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 3Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4
(Date:7/27/2014)... 27, 2014 Alta Resources , ... (BPO) for Fortune 500 brands, announced today that it ... locations in Wisconsin, California, Florida and the Philippines. , ... health-insurance clients, which have seasonal ramp-ups that require additional ... November 2014 through February 2015. As more consumers become ...
(Date:7/27/2014)... July 27, 2014 Discount-Dress.com is a ... products for its current and prospective customers. Each of ... Additionally, it has a team of considerate designers; they ... offering perfect dress solutions. , Recently, the firm ... dresses . To top it all off, these brand-new ...
(Date:7/27/2014)... OH (PRWEB) July 27, 2014 Wright ... Louisiana has filed a GranuFlo lawsuit against ... clinics in Louisiana over the recalled dialysis drugs GranuFlo ... state’s Medicaid program by not disclosing the heart attack ... lawsuit contends that Fresenius notified its own clinics, practitioners ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 Dr. Rob Agosto, ... Companies since 2006 and had until recently been caring for ... has joined Dr. Chris Steacy, DC at Sport and Spine ... , “For many years, the patients of Columbia have lived ... expertise of Dr. Steacy. We worked to ...
(Date:7/27/2014)... According to the 3-Week Diet system review recently updated ... help both men and women lose weight naturally without medications. ... now by Vkool, was developed by Brian Flatt, a nutrition ... 3-Week Diet system, many people have used it to find ... hips, belly, and buttocks. , The 3-Week Diet system ...
Breaking Medicine News(10 mins):Health News:Alta Resources to Fill Approximately 2,500 Positions 2Health News:Alta Resources to Fill Approximately 2,500 Positions 3Health News:New Cocktail Party Dresses From Leading Online Supplier Discount-Dress.com Receive National Attention 2Health News:Louisiana Files GranuFlo Lawsuit Against Fresenius Medical Care over Its Recalled GranuFlo and NaturaLyte Dialysis Drugs 2Health News:Louisiana Files GranuFlo Lawsuit Against Fresenius Medical Care over Its Recalled GranuFlo and NaturaLyte Dialysis Drugs 3Health News:Louisiana Files GranuFlo Lawsuit Against Fresenius Medical Care over Its Recalled GranuFlo and NaturaLyte Dialysis Drugs 4Health News:Louisiana Files GranuFlo Lawsuit Against Fresenius Medical Care over Its Recalled GranuFlo and NaturaLyte Dialysis Drugs 5Health News:Sport and Spine Rehab of Columbia Announces the Addition of Dr. Rob Agosto, Doctor of Physical Therapy to Its Clinical Team 2Health News:3-Week Diet System Review Exposes Brian Flatt's Weight Loss Methods – Vkool.com 2
... DALLAS, Jan. 12 Affiliated Computer Services, Inc. (NYSE: ... provide Regence with Health Savings Account (HSA) administration services ... counties of Washington. Regence members will be offered the ... the addition of Regence, the largest health insurer in ...
... 12 , - Small ... , With the introduction of ... messaging device, NEC sets new standards in,mobile communications and ... innovations. , (Photo: http://www.newscom.com/cgi-bin/prnh/20090112/333834 ...
... publication of its kind aimed at healthcare fraud ... (HCI), a Verisk HealthCare company and a provider ... solutions for healthcare claims payors, announced today that ... Profiler Magazine is the nation,s ...
... Jan. 12 Wyeth Pharmaceuticals, a division of Wyeth ... announced that the companies have entered into a worldwide ... based on Santaris Pharma,s proprietary Locked Nucleic Acid (LNA) ... microRNAs (miRNAs) and messenger RNAs (mRNAs) as a means ...
... Corporation,(Nasdaq: ALUS ), the worldwide leader ... patients, today announced preliminary,unaudited record fourth quarter and ... Fourth quarter 2008 revenue improved ... of approximately $3.8 million, compared with $2.7 million ...
... to Drive Real-Time Pharmacy Utilization Management DecisionsNEWPORT ... The TriZetto Group, Inc. and Sanovia Corporation ... offer the market,s first platform that integrates ... automate prior-authorizations of medications and help plans ...
Cached Medicine News:Health News:ACS to Provide HSA Product to Regence; ACS HSA Solution Now Offered by Blue Cross Blue Shield Plans in 28 States 2Health News:NEC's new M155 Messenger Sets New Standards in Mobile Messaging 2Health News:HealthCare Insight(R) Launches Industry Fraud Magazine 2Health News:Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines 2Health News:Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines 3Health News:Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines 4Health News:Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue 2Health News:Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue 3Health News:TriZetto, Sanovia Join Forces to Offer First Integrated Platform That Helps Payers Control Pharmacy Costs 2Health News:TriZetto, Sanovia Join Forces to Offer First Integrated Platform That Helps Payers Control Pharmacy Costs 3
... 80 mm. Grooved buckle. Size: 2.3 x 4.0 ... original Scleral Sponge II line designed by Harvey ... closed cell sponge which is non-toxic and non-antigenic. ... scleral intrusion. These implants are packaged sterile and ...
For use with E5381 700 Circling Band (240 style)....
For use under curved implants. Indications: When additional buckling is required in the meridional direction. Overall length: 12.0 mm....
For use with E5381 600 Circling Band (40 style)....
Medicine Products: